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“It seems to me what is called for is an exquisite balance
between two conflicting needs: the most skeptical scrutiny of all
hypotheses that are served up to us and at the same time a great
openness to new ideas … If you are only skeptical, then no new
ideas make it through to you … On the other hand, if you are
open to the point of gullibility and have not an ounce of skeptical
sense in you, then you cannot distinguish the useful ideas from the
worthless ones.”
“The Burden of Skepticism” (1987)
 (CARL SAGAN).
(Página deixada propositadamente em branco)
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INTRODUCTION
This book has been compiled to provide scientists with a convenient
method for the tentative identification of phenolic acids, dihydroflavonoids,
flavones and flavonols in extracts of  plants or plant-derived material.
These compounds are virtually ubiquitous in land-based green plants
(Markham, 1982) and represent about 2% of all carbon biosynthesised by
plants (Smith, 1972).  Representatives of all or some of these will be
found in most plant extracts and are widely encountered in foods and
beverages (Kyle and Duthie, 2006). Although numerous publications
describing the use of absorption spectroscopy in the identification of these
phenolics have appeared, (e.g. Jurd, 1962; Mabry et al., 1970; Markham,
1982; Markham and Bloor, 1998), the advent of high performance liquid
chromatography with on-line photo-diode array detection (HPLC/DAD)
has provided a highly effective technique for the separation and tentative
identification of such compounds (Markham and Bloor, 1998). This tech-
nique provides two key characters for each component, the retention time
(RT) and the absorption spectrum. The combination of these two features
enables the identification of the component type, and by reference to
appropriate standards, provides structural information and perhaps identi-
fication. The data presented in this volume relate to a selection of authen-
tic standard compounds from the collection of one of us (K.R.M) and
will enable the reader to determine structural features of unidentified com-
pounds through the analysis of the fine structure of the absorption spec-
trum. The on-line measured spectra in this book represent uniquely pure
Maria da Graça Campos & Kenneth R. Markham
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compounds, initially purified by 2D-PC or crystallization and, for this
compilation, by HPLC/DAD. Thus, the fine structure detail within spec-
tra is reliable, and many correlations based on this are described here for
the first time. Previous compilations of spectra, typically derived from
samples purified by 2D-PC or crystallization, are less reliable in this re-
spect. Additionally, such spectra are measured in solvents which differ
from those used for HPLC. This can affect peak maxima and fine struc-
ture detail.
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CHAPTER 1
1. Origin and function of flavonoids and phenolics acids.
Representatives of the groups of natural products chosen for this
compilation are found in all land-based green plants. They are all products
of the shikimate (phenylpropanoid) biosynthetic pathway (Haslam, 1974;
Dewick, 2001), which produces cinnamic acid (via phenylalanine). Cin-
namic acid gives rise to both benzoic acids and hydroxycinnamic acids.
One of the latter, 4-hydroxycinnamic acid, as its coenzyme A derivative, is
the product which, when elaborated further by interaction with three
malonyl-coenzyme-A units, produces the primary flavonoid (chalcone/fla-
vanone) from which all other flavonoids are derived (Heller and Forkman,
1994; Davies and Schwinn, 2006). The most common of these flavonoids
by far, are the flavones and flavonols which occur almost exclusively as
glycosides within plants and as aglycones on the plant surface. Flavonoids
other than those studied here, e.g. isoflavonoids, anthocyanins, aurones
etc., have a more restricted distribution in the plant kingdom and are
frequently associated with specialized plant organs.
Flavonoids (and to some extent phenolic acids), perform a range of
functions in green plants (Gould and Lister, 2006). Protective functions
include UV screening, free radical scavenging and anti-microbial and anti-
feedant activity. Signalling functions include flower and fruit colouration,
involvement in the initiation of root nodule formation and pollen tube
growth. They also function as controllers of enzyme activity. Some of
Maria da Graça Campos & Kenneth R. Markham
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these activities have found application in the promotion of human health
and well-being (Clifford and Brown, 2006). Their free radical scavenging
capability in particular, is one of the major reasons why foods rich in
flavonoids such as fruit, vegetables, tea, red wine, etc., are thought to
protect against (oxidative) degenerative diseases such as arthritis, cancer and
hypertension. Vitamin sparing and regeneration is thought to be another
function of flavonoids in the diet.
2. Use of this book
Providing that the HPLC methodology used here for obtaining RTs
and absorption spectra is adhered to, the data obtained in an analysis may
be directly compared with the data presented here. The first step in a
tentative identification involves interpretation of the absorption spectrum
to determine compound type, i.e. aromatic acid, dihydroflavonoid, fla-
vone, flavonol, or “other”. Comparison with reference spectra in this com-
pilation should provide this information. To aid in compound identifica-
tion two tables of reference compounds are included, one (Table 1) in
which the reference compounds are grouped according to general com-
pound type, e.g. aromatic acids, dihydroflavonoids, flavones, and flavonols,
and another (Table II) in which they are listed in order of RT. The
absorption spectra are also reproduced so that fine structural features of
spectra can be seen. Common names are used where available and struc-
tures represented by such names may be found in chemical supply cata-
logues (aromatic acids) or standard flavonoid texts, (e.g. Hattoti, 1962;
Grippenberg, 1962; Markham, 1982; Harborne, 1994, Campos, 2005).
When structure information on an unknown compound in one of
the above categories is required, the first step using the information in this
compilation would be to compare the absorption spectrum (of the glyco-
side or its derived aglycone) with those reference spectra presented here. If
an exact match can be found, then a comparison of RTs will give an
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indication of whether the unknown is likely to be identical to the refer-
ence. If both the absorption spectrum and the RT match, then proof of
structure would require co-chromatography of the unknown with an
authentic sample (a range of commercial sources of such compounds is
provided herein). Co-injection of equivalent amounts of both compounds
should produce a single, clean peak if they are identical.
If an exact match for the spectrum can be found, but the RT differs,
then it is likely that the unknown differs from the reference only in the
number or nature of sugars attached to the glycosylated site, or in the
nature of a substituent, e.g. O-methyl compared with O-ethyl, or pre-
sence/absence of an aliphatic acyl group on a sugar. If the unknown is
eluted faster than the reference (i.e. has a lower RT), then because the
chromatographic solid phase is non-polar relative to the polar solvent, this
indicates that the unknown is more polar (e.g. contains more sugars or a
sugar of higher polarity). Conversely if the unknown is slower eluting
than the reference (i.e. higher RT), then the unknown is less polar (e.g.
contains fewer sugars or a sugar of lower polarity or contains an aliphatic
acyl group).
In the event that no exact match for the absorption spectrum can be
found amongst the reference spectra, a close match may indicate that the
unknown is related to the reference, perhaps with the same oxygenation
pattern but with a different substitution pattern. In the accompanying
text, a number of rules are outlined which will help define the effects
expected from varying substitution patterns.
With regard to compound identification, a word of caution. As has
been stated previously (Markham, 1982), reliable proof of identity of an
unknown with a reference compound requires comparison via a mini-
mum of three characters. RT and an absorption spectrum comprise only
two, and ideally any identification should include one other technique as
well. For example TLC, 2D-PC, a mass spectrum or an nuclear magnetic
resonance spectrum, or hydrolysis and product identification (by HPLC).
Maria da Graça Campos & Kenneth R. Markham
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For further information on the application of these techniques to fla-
vonoid structure elucidation see Markham and Geiger, 1994 (1H-nmr),
Agrawal, 1989, and Markham and Chari, 1982 (13C-nmr), Mabry and
Markham, 1975, and Wolfender et al., 1992 (mass spectrometry) and
Markham, 1982 (chromatography and hydrolysis).
3. Chromatographic methodology
Retention times for the reference standards in this compilation were
measured on a Merck Lichrospher 100 end-capped RP-18 column (11.9 x
0.4 cm, i.d. 5µm) using a Waters (Milford, MA, USA) 600E solvent
controller, a Waters 996 photodiode array detector, a Jasco (Tokyo, Japan)
851-AS intelligent sampler and a Millennium32 (Milford, MA, USA)
Version 3.05.01 software. Elution was carried out using a flow rate of 0.8
ml.min-1 at 24oC.
The solvents comprised water adjusted to pH 2.5 with orthophos-
phoric acid (A) and acetonitrile (B) mixed using a linear gradient starting
with 100% A, decreasing to 91% over the next 12 min to 87% over the
next 8 min and to 67% over the next 10 min. After holding the solvent
at this composition for 2 min, A was decreased to 57% over the next 10
min, and then held at this level until the end of the 60 min analysis.
Spectral data for all peaks were accumulated in the range 220-400
nm. The linearity of the detector response was checked with the stan-
dards, quercetin, quercetin-3-O-rhamnoside (quercetrin) and quercetin-3-
O-rutinoside (rutin) (Amiot et al., 1988; Campos et al., 1990; Campos,
1997).
Note that if an RP-18 column with different dimensions is used, the
retention time data obtained will be either higher (columns of larger size)
or lower (columns of smaller size), but the sequence of retention times of
the same mixture of compounds will remain the same.
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4. General notes on spectra and presentation
Throughout this book reference is made to the sites of substitution
in flavonoids, to the A-, B- and C- rings of flavonoids, and to bands I,
IIa and IIb in the absorption spectrum and hypsochromic and bathochromic
shifts in these bands. Substitution sites are defined by the number of the
carbon atom, and the numbering of carbon atoms on the flavonoid nucleus
















Figure 1: Flavone nucleus
Also in this figure are the designations of the A-, B- and C- rings.
Figure 2 illustrates certain features of the flavonoid absorption spectrum,
including the band I, IIa and IIb definitions, a commonly encountered
shoulder, and an instrument generated aberration. This aberration is visible
in a number of spectra at about 370nm and is caused by the changeover
from the UV to the visible lamp in the detector. This may take the form of
a shoulder on the side of a peak or a sharp valley near the apex of a peak.
Other detectors may or may not produce this, but it has been retained in
the spectra presented here so as to ensure no loss of spectral accuracy.
When comparisons of two or more spectra are discussed in the text,
the difference between the wavelength of the same absorption peak in
each spectrum is referred to as a hypsochromic or bathochromic shift. The
former refers to a shift to a lower wavelength and the latter to a shift to
higher wavelength.
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16
5. Useful sources of reference compounds (not exhaustive)
Apin Chemicals Ltd (UK):  http:// www.apinchemicals.com
Carl Roth GmbH + Co.:  http://www.carl-roth.de








Figure 2 – Illustration of certain features of the flavonoid absorption
spectrum, including the band I, IIa and IIb designations,
shoulder examples including the changeover from the UV to
the visible lamp.












Phenolic acids of the benzoic or cinnamic acid type are commonly
found as derivatives in plant extracts and are frequently encountered as
acyl groups attached to flavonoid glycosides. For analysis these are readily
cleaved from the glycoside with alkali (see Markham, 1982). In some
respects their absorption characteristics are analogous to the B-ring contri-
bution in the spectra of flavones and flavonols. When the substitution
pattern is symmetrical in benzoic acids and in some cinnamic acids, for
example in benzoic (1), gallic (7), cinnamic (9), p-hydroxybenzoic (3),
syringic (8) and sinapic (16) acids, the spectrum is comprised of only one
absorption band.
In the simplest example, benzoic acid, the spectrum displays a single
absorption band at 272nm. This spectrum is not noticeably altered by the
introduction of the conjugated side-chain in cinnamic acid, and in fact the
easiest way to distinguish these acids by HPLC/DAD is from their very
different retention times of 31.5 min. (benzoic) and 41 min. (cinnamic).
Hydroxylation of benzoic acid at the para position produces a 19nm
hypsochromic shift of the major absorption band from 272nm to 255nm
whereas in cinnamic acid, para-hydroxylation produces the reverse effect, a
bathochromic shift of similar proportions (cf. spectra 1, 3 and 9, 12).
When hydroxylation/methoxylation substitution is unsymmetrical, e.g. 2,4-
dihydroxybenzoic acid (4), a double absorption peak may be produced. This
phenomenon is also seen in the spectra of flavones and flavonols (q.v.).
Maria da Graça Campos & Kenneth R. Markham
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The monohydroxylated cinnamic acids, ortho-, meta- and para-
coumaric acids (10, 11 and 12) are readily distinguished by their absorp-
tion spectra. In general terms, as the distance between the hydroxyl and
the side chain decreases (i.e., from para to meta to ortho), the separation
of the two absorption bands increases. The commonly encountered para-
coumaric acid possesses a characteristic double peak absorption at about
293sh and 308nm which readily identifies the presence of it or its deriva-
tives in acylated flavonoids and anthocyanins. The spectra of the ortho-
and meta- coumaric acids retain a reduced absorption at about 320nm
and exhibit their other major absorption band at significantly lower wave-
lengths than para-coumaric acid.
Caffeic acid is often found as its 3-methyl ether, ferulic acid (14) in
acylated flavonoids. The spectrum of ferulic acid is very similar to that of
caffeic, but ferulic acid can be readily distinguished by its longer retention
time (31,4 min. versus 23,5 min.). Caffeic acid 4-methyl ether, isoferulic
acid (15) is also difficult to distinguish by its absorption spectrum alone.
However, isoferulic acid is rarely, if ever, encountered as an acyl group in
flavonoids. It can only be distinguished from ferulic acid with any certainty
by co-HPLC with an authentic standard. Flavonoid glycosides acylated
with ferulic acid are readily distinguished from the equivalent caffeoylated
flavonoid glycosides, by their significantly higher retention times.
2. DIHYDROFLAVONOIDS
The dihydroflavonoids possess spectra rather similar to those of the
benzoic acids. This is due to the fact that the major chromophore in
dihydroflavonoids is the A-ring which is isolated electronically from the
lower absorbing B-ring. The spectrum of a 5-deoxy-dihydroflavone like
fustin (22) could be confused with that of ortho-coumaric acid (10),
however these compounds are readily distinguished by their very different
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retention times. Also similar are the spectra of naringenin (19), eriodictyol
(20), and dihydroquercetin (23) and meta-coumaric acid. Again, these are
generally easy to distinguish from their retention times, but dihydroquercetin
and meta-coumaric acid have similar RTs and are difficult to distinguish.
7-O-glycosylation of dihydroflavonoids (e.g. as in eriodictyol-7-O-
neohesperidoside, 21) has little effect on the absorption spectrum. Nor
does the conversion of a dihydroflavone to a dihydroflavonol (e.g.
eriodictyol, 20, to dihydroquercetin, 23) through the addition of a
hydroxyl at C-3. HPLC retention times however do permit distinctions,
e.g. eriodictyol (RT = 40,8 min.) and dihydroquercetin (RT = 32,8 min.).
Interestingly eriodictyol-7-O-neohesperidoside (21) has the same retention
time (and spectrum) as dihydroquercetin and these would need to be
distinguished via acid hydrolysis to produce the HPLC distinguishable
aglycones.
3. FLAVONES
The absorption spectra of flavones and flavonols typically exhibit
two bands, band I in the range 320-385nm and band II in the range 250-
285nm. When flavones lack B-ring substitution, or possess a 4’-oxygen-
ated B-ring, band II of the spectrum appears as only one peak. The
introduction of additional B-ring oxygenation commonly produces a double
band II (bands IIa and IIb). Band IIa may appear simply as a shoulder on
the long wavelength side of band IIb (see later discussion).
3.1. Flavones with minimal or unusual oxygenation
 When oxygenation is present only in the A-ring as in chrysin (25)
and baicalein (26) and includes a 5-hydroxyl, the spectrum is dominated
by band II. The introduction of B-ring oxygenation as in 5-hydroxy-4'-
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methoxyflavone (24) however, enhances the intensity of band I. In the
spectrum of 5,7,2’-trihydroxyflavone (27), relative to that of chrysin (25),
the introduction of the 2’-hydroxyl has produced a marked enhancement
of band I, with little change being evident in band II. This enhancement
in band I is even greater when the B-ring oxygenation is at C-4’ as in
apigenin (28).
In baicalein (26), which lacks B-ring oxygenation but contains an addi-
tional A-ring hydroxyl relative to chrysin, band II exhibits a significant
bathochromic shift (277nm in baicalein, compared with 266nm in chrysin).
3.2. The apigenin (5,7,4’) oxygenation pattern
The absorption spectra of flavones with the 5,7,4’ oxygenation pat-
tern are characterized by two major absorption bands, band I at 325-
337nm and band II at 265-275nm (see apigenin, 28). Derivatisation of
one or more of the three hydroxyls of apigenin can be detected from
slight changes in this spectrum. For example 7-O-glucosylation (see apige-
nin-7-O-glucoside, 31, and apigenin-7-O-apiosylglucoside, 30) causes the
290nm shoulder visible in the spectrum of apigenin, 28, to disappear. 7-
O-methylation however does not produce this effect (see genkwanin, 36).
Methylation at the 4’-hydroxyl is evident from a marked hypsochromic
shift in band I of 7-8nm (compare acacetin-7-O-neohesperidoside, 37,
and apigenin-7-O-neohesperidoside, 29).
3.2.1. 6- and 8-substitution effects
6- and 8-C-glycosylation has little or no effect on band I absorption,
and the rules defined earlier for the effect of a second B-ring hydroxyl on
band still apply (see spectra of vitexin, 32, and orientin, 52).
The effect of 6-C-glycosylation on band II however differs from that
of 8-C-glycosylation. 6-C-glycosylation (e.g. in isovitexin, 33, and isorientin,
53) causes an apparent bathochromic shift in the major peak in band II
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relative to the aglycone, where as 8-C-glycosylation (e.g. in vitexin, 32,
and orientin, 52) has little if any effect.
Further O-glycosylation of the sugar in vitexin (see 2’’-O-
glucosylvitexin, 34) also has no effect on the absorption spectrum. Indeed
the spectra of apigenin, vitexin and 2’’-O-glucosylvitexin are indistinguish-
able. These compounds however are readily distinguished from their re-
tention times of 45.1, 32.6 and 31.7 min. respectively.
Methoxylation at C-6 produces a bathochromic shift in band II
similar to that seen with 6-C-glycosylation (see scutellarein – 6 , 4’-
dimethylether, 40).
Two examples of 8-oxygenated apigenins are presented here, 38 and
39. The spectrum of 8-hydroxyapigenin-8-O-glucuronide (38) resembles
that of the apigenin itself, and it appears that 8-O-glycosylation of 8-O-
hydroxyapigenin negates the effect of 8-hydroxylation on the aglycone,
apigenin (28). In contrast, the spectrum of a 7-O-glycosylated 8-hydro-
xyapigenin such as 8-hydroxyapigenin-7-O-allosylglucoside (39) reflects the
effect of 8-hydroxylation. This spectrum possesses a most unusual set of
absorption peaks with a major (additional) peak at ca. 300nm. Similar
distinctions between these two different glycosylation patterns and their
effects on absorption spectra have been observed previously (Markham
and Given, 1988).
3.3. The luteolin (5,7,3’,4’) oxygenation pattern
The absorption spectra of flavones with the 5,7,3’,4’-oxygenation
pattern typically possess three absorption peaks at about 254, 267 and
345-350nm (see luteolin, 42) The doubled band II, bands IIa and IIb,
seem to be characteristic of the 3’,4’-dioxygenation pattern compared to
the 4’-oxygenation pattern in apigenin. As in the spectrum of apigenin, a
shoulder at around 290nm is evident in the spectrum of luteolin. 7-O-
Glycosylation of luteolin (see luteolin-7-O-glucoside, 43), luteolin-7-O-
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rutinoside, 46, and luteolin-7-O-glucurono-glucuronide, 47) causes this
shoulder to disappear as was seen with apigenin. When glycosylation is
present at both the 7- and the 4’-hydroxyls, the spectrum is modified
such as to appear like that of a 7-O-glycosylated tricin (see luteolin-7,4’-
di-O-glucuronide, 48, and tricin-7-O-rhamnoglucuronide, 71). The reten-
tion times however readily distinguish these compounds (30.7 and 36.2
min. respectively).
3’-O-Glycosylation has a dramatic effect on the spectrum of luteolin.
Band IIa at 268nm appears very prominent through a hypsochromic shift
of band IIb to around 240nm. Band I also suffers a hypsochromic shift
to 342nm (see luteolin-3’-O-glucoside, 44). The spectrum in effect be-
comes more apigenin-like with the 3’-O-glycosylation negating the influ-
ence of the 3’-hydroxyl on the spectrum. Additional 7-O-glycosylation
(see luteolin-7,3’-O-diglucuronide, 49) causes the disappearance of the ca.
290nm shoulder as has been observed before with 7-O-glycosylation.
As with 3’-O-glycosylation, 4’-O-glycosylation of the luteolin nucleus
produces an enhancement of band IIa (e.g. in luteolin-7,4’-di-O-glucu-
ronide, 48), but unlike 3’-O-glycosylation, glycosylation at the 4’-hy-
droxyl produces a sizeable hypsochromic shift in band I. When both the
3’- and 4’-hydroxyls are glycosylated as in luteolin-3’,4’-di-O-glucuronide
(50), the enhancement of band IIa is accompanied by a marked drop in
the intensity of band I as well as a major hypsochromic shift. The overall
effect is to reduce the influence of the 3’- and 4’-hydroxyl groups on the
spectrum such that in general form it approaches that of 5,7-
dihydroxyflavone (chrysin, 25). Additional 7-O-glycosylation as in spec-
trum 51, has little further discernable effect.
5-O-glycosylation of luteolin produces a spectrum similar to that of
luteolin and, because luteolin-5-O-glucoside (45) lacks 7-O-glycosylation,
the spectrum also contains a shoulder at ca. 290nm. A distinctive shoulder
at 240nm appears in the spectrum of luteolin-5-O-glucoside (and in
chrysoeriol-5-O-glucoside, 56).
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O-Methylation of luteolin at the 3’-hydroxyl (see chrysoeriol) has
little effect on the absorption spectrum apart from deepening the valley
between bands IIa and IIb at 269 and 252nm respectively. This relative
lack of effect is evident also from a comparison of the 5-O-glucosides of
luteolin and chrysoeriol (45 and 56), and the 6,8-di-C-glucosides of both
(54 and 58).
3.3.1. 6- and 8-substitution effects
For 6- and 8-C-glycosylation effects refer to section 3.2.1 above.
Additional 6- or 8-oxygenation produces its main effects on band II
(see 6-hydroxyluteolin, 61). In the spectrum of 6-hydroxyluteolin (61),
band IIa is shifted to about 278nm from near 267nm in luteolin (42).
Glycosylation at the 7-hydroxyl is evidenced, as in the apigenins and
luteolins, by a loss of the slight shoulder at about 310nm and by a
marked enhancement of band IIa (see the 7-glucosylglucoside, 62, 7-
xylosylglucoside, 63, and 7-xylosylxyloside, 64, of 6-hydroxyluteolin). These
compounds although not readily distinguishable from their spectra,
possess significantly different RTs of 29.7, 38.7, and 34.9 min. respectively.
The only 8-oxygenated luteolin aglycone derivative included in this
work is 7-hydroxy-5, 8, 3’, 4’-tetramethoxyflavone (74), but because of
its extensive methylation, spectral shifts relative to luteolin have little
significance. Comparison with the only other 5-O-substituted luteolin,
the 5-O-glucoside, (45), suggest that the major effect of 8-oxygenation is,
as with 6-oxygenation, a bathochromic shift and enhancement of band
IIa. This effect is also seen in 8-hydroxyluteolin when glycosylated at the
7-hydroxyl (65), but not when glycosylated at the 8-hydroxyl (66). In
fact when 8-hydroxyluteolin is glycosylated at the 8-hydroxyl, the spec-
trum strongly resembles that of luteolin (42) as was the case in the
analogous apigenin series (q.v.). Thus, such glycosylation appears to negate
the effect of 8-hydroxylation on the luteolin spectrum which is so evident
with the 7-O-glucoside (65). Data supporting this conclusion have been
published by Markham and Given (1988).
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3.4. The tricetin (5, 7, 3’, 4’, 5’) oxygenation pattern
The spectrum of tricetin (67) differs from that of the related luteolin
(42) in having its major band IIa absorption at 266nm and in the relative
increase in the intensity of band I at 350nm. The shoulder at ca. 290nm
diminishes in size on glycosylation at the 7-hydroxyl (see tricetin-7-O-
glucoside, 68), as has been observed in the apigenin and luteolin series.
Comparison of the spectra of tricetin (67) and its 3’,5’-dimethyl ether
tricin (69), reveals that these two compounds (and their equivalent deriva-
tives) are not easy to distinguish from their absorption spectra alone,
although bands IIa and IIb do appear better defined in the latter. However
they are well separated on HPLC with retention times of 38 and 46 min
respectively. Glycosylation of tricin at the 5-hydroxyl (see tricin-5-O-glu-
coside, 70) has little effect on the absorption spectrum while glycosylation
at the 7-hydroxyl brings about the same change as observed previously, i.e.
the diminution of the shoulder at ca. 296nm. Glucosylation at the
5-hydroxyl has a major effect on the polarity, judging by the large change
in retention time of about eleven minutes, an effect comparable with that
of 7-O-glycosylation (cf. tricin-7-O-rhamnosylglucuronide, 71).
When tricetin is O-methylated at the 3’, 4’, and 5’-hydroxyls a ma-
jor change in the spectrum is observed. A hypsochromic shift in band I of
19nm relative to tricetin, and 23nm relative to tricin is produced,
together with a marked decrease/loss of band IIb (see spectrum 72). The
spectral change is remarkable, and reduces the absorption spectrum to one
resembling genkwanin (36), a flavone whose retention time of 57.1 min. is
not too dissimilar from that of tricetin-3',4',5',-trimethylether at 54.7 min.
3.4.1. 6- and 8- oxygenation effects
In the only example in this compilation, scaposin (73), the major
effect of introducing methoxyl groups at C-6 and C-8 appears to be a
bathochromic shift of band II to around 280nm. The hypsochromic shift
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of band I to about 330nm is probably caused by methylation of the
4’-hydroxyl group as seen in the spectrum of tricetin-3’,4’,5’-trimethyl
ether (72). It is noteworthy that even in the absence of 7-O-glycosylation,
no shoulder is evident in the 295nm region. Additional relevant informa-
tion regarding the effects of introducing oxygenation at C-6 and C-8 is
presented for the flavonols (Section 4.1).
4. FLAVONOLS
4.1. Simple unusual oxygenation patterns
When 3-hydroxyflavone [λ
max.
 239, 243sh, 306, 344nm (Mabry et
al., 1970)] is substituted with a hydroxyl group at C-2’, the main effect
on the spectrum is a decrease in the intensity of band I relative to band II.
In 2’-hydroxyflavonol (75), the same three absorption bands as in
3-hydroxyflavone are present, but at somewhat shorter wavelengths.
Oxygenation of 3-hydroxyflavone at the 3’ and 4’ positions in con-
trast, increases the intensity of band I such that the intensity exceeds that
of band II (see 3’,4’-dihydroxyflavonol, 77).
Of interest in the spectrum of 3',4'-dihydroxyflavonol (77), is the
lack of a doubled band II which is seen in most other 3’,4’-dioxygenated
flavonoids. It would seem that the presence of a 5-hydroxyl is a necessary
prerequisite for this doubling to appear, at least in 3-hydroxyflavones (see
also fisetin, 82, and 3',4'-dimethoxyflavonol 78). The absence of a
5-hydroxyl also appears to enhance the shoulder between bands I and II,
i.e. in the 290-315 range (compare fisetin, 82 with quercetin, 108, and
7,8,4’-trihydroxyflavonol, 80, with the herbacetin derivatives, 103 and 104).
The absence of B-ring oxygenation as in galangin, 76, surprisingly
has little effect on the form of the spectrum (cf. kaempferol, 83)
although the relative intensity of band I is significantly reduced.
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4.2. The kaempferol (3,5,7,4’) oxygenation pattern.
The spectrum of kaempferol (83) resembles that of 5,7-
dihydroxyflavonol (galangin, 76), but has a more intense band I. This
spectrum is largely unaffected by 4’-O-methylation (see 4’-O-
methylkaempferol, 97), but undergoes a noticeable change when kaempferol
is derivatized at the 3-hydroxyl. With 3-glycosylation band I undergoes a
hypsochromic shift of some 15-20nm, and this is accompanied by a
relative drop in intensity (see kaempferol glycosides 84, 85, 87, 88 and
89). When rhamnose is the sugar, this hypsochromic shift is somewhat
greater (see comment on quercetin in section 4.3). Distinction of
kaempferol-3-O-rutinoside (89) from the 3-O-neohesperidoside, 88 (which
possess the same absorption spectra and produce the same hydrolysis prod-
ucts) is easily achieved from the retention time. The 1-6 linkage (rutinose)
causes the molecule to elute about 2 min. later than the 1-2
(neohesperidose) linkage.
7-O-glycosylation of kaempferol as in kaempferol-7-O-glucoside (86)
has very little effect on the absorption spectrum, and thus it is not surpris-
ing that when kaempferol is glycosylated at both the 3- and 7-hydroxyls,
(spectra 92, 93, and 94), the spectra resemble those of kaempferol 3-O-
glycosides. An exception is the sinapoylated derivative, (96), where the
superimposition of the spectrum of the sinapoyl group produces both an
enhanced band I and caused an apparent shift back to 331nm. The nature
or existence of any acylation however may not be evident from the absorp-
tion spectrum, e.q. in kaempferol-3-O-(6-acetylglucoside)-7-O-glucoside (94).
In such cases, RTs values are often of value since acylation normally increases
the retention time, with each acyl group increasing it to a different extent.
4.2.1. 8-substitution-effects
8-hydroxylation of kaempferol produces herbacetin. Its 7-O-methyl
ether (105) has a spectrum quite different from that of kaempferol. In
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particular, both bands I and II exhibit a bathochromic shift and the
shoulder(s) in the 320nm region are markedly enhanced. Methylation of
the 8-hydroxyl makes little difference in the absorption spectrum, but the
retention times permit ready distinction (see 8-O-methyherbacetin, 103).
The spectrum is also barely changed by 8-O-glucosylation, but here again
the retention time permits ready distinction (see 8-O-glucosylherbacetin,
101). Additional 3-O-glycosylation in an 8-O-substituted herbacetin how-
ever brings about a notable change in the absorption spectrum. In both
herbacetin-3-O-glucoside-8-O-glucuronide (102) and 8-O-methylherbacetin-
3-O-sophoroside (104), band I has suffered a major drop in intensity and
a 15-20nm bathochromic shift, changes also observed with some other 3-
O-glycosides.
3-O-Glycosylation of 7-O-methylherbacetin (105) (itself producing
an unusual spectrum), produces a very unusual, almost non-flavonoid
absorption spectrum (106). In the only example of 7,8,3-substitution of
herbacetin, 7,8-di-O-methylherbacetin-3-O-(2-O-ferulylglucoside), (107), the
spectrum has reverted to what appears to be an apigenin type. However,
with band(s) I in the 7- and 7,3-disubstituted herbacetins being of rela-
tively low intensity, it seems likely that in 107 these bands have been
masked by the absorption of the ferulic acid acyl group which would
absorb strongly at 329nm.
4.3. The quercetin (3,5,7,3’,4’) oxygenation  pattern
With 3’,4’-dihydroxylation in the B-ring, quercetin (108) exhibits a
doubled band II, although band IIa appears only as a shoulder on the
dominant band IIb. It should be mentioned that occasionally kaempferol
glycosides also exhibit bands IIa and IIb (see kaempferol-7-O-glucoside,
86), although a single band II absorption is the norm for kaempferol
glycosides. As with kaempferol, 3-O-glycosylation of quercetin causes a
hypsochromic shift in band I together with a reduction in intensity rela-
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tive to band II (see quercetin-3-O-galactoside and quercetin-3-O-glucoside,
109, 110,). This is even more marked in the 3-O-rhamnoside (112)
spectrum in which the hypsochromic shift is ca. 25nm compared with ca.
18nm with the other 3-O-glycosides. It is thought that the α-linkage of
the rhamnose to the 3-hydroxyl causes the sugar to interfere with the free
rotation of the B-ring in this compound. This in turn leads to a reduction
in π-electron overlap between the B- and C-rings.
In the series of 3-O-glycosides studied, although most of the absorp-
tion spectra are indistinguishable, the sugar moiety can be determined from
the HPLC RTs. Thus the galactoside = glucoside < arabinoside < rhamno-
side, a sequence probably true also for glycosides of other flavonoids.
7-O-Glycosylation has little effect on the absorption spectrum of
quercetin (see quercetin-7-O-glucoside, 113) apart from the disappearance
of the shoulder at about 295nm (as observed with the flavones).
Permethylation of quercetin (see quercetin-pentamethylether, 124) pro-
duces the expected hypsochromic shifts in both bands.
The effects of methylation of the 3’- and 4’-hydroxyl groups in
quercetin are evident from a comparison of the equivalent quercetin (108),
isorhamnetin (3’-O-Me) (118) and tamarixetin (4’-O-Me) (122) spectra.
Thus, when the spectra of the isorhamnetin 3-O-galactoside (119), 3-O-
glucoside (120) and 3-O-rutinoside (121) are compared with those of 3-
glycosylated quercetins (e.g. 109, 110), the differences are slight. One
minor difference is a 3nm hypsochromic shift in the band I absorption of
the isorhamnetins, and another is the resolution of bands IIa and IIb,
which is more pronounced in the isorhamnetin glycosides.
Methylation at the 4’-hydroxyl however, produces no obvious change
in the quercetin spectrum (see the spectra of quercetin-7-O-glucoside, 113,
and tamarixetin-7-O-rutinoside, 122). O-Methylation does normally cause
an increase in the retention time (e.g. quercetin, 41.9 min; isorhamnetin,
47.3 min; 3-O-methylquercetin, 43.4 min.) and so, the similar absorption
spectra should not lead to miss-identification.
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Further methylation of isorhamnetin glycosides at the 5-hydroxyl
(e.g. in 5-O-methylisorhamnetin-3-O-glucoside 123) does not noticeably
affect the form of the isorhamnetin spectrum (see isorhamnetin-3-O-glu-
coside, 120). The effect of 5-O-methylation on the RT at around 2.5
min. is comparable to that seen for methylation at other hydroxyls in
quercetin glycosides.
4.3.1. 6- and 8-substitution-effects
The major effect of the introduction of 6-oxygenation into quercetin
can be seen in the comparison of quercetin-7-O-glucoside (113) and
quercetagetin-7-O-glucoside (127). Whilst a hypsochromic shift is evident
in band I, band II has undergone a noticeable bathochromic shift and band
IIa has intensified. These effects are not seen with the introduction of a
 6-methoxyl however. Thus the spectrum of patuletin-7-O-glucoside (126)
is essentially indistinguishable from that of quercetin-7-O-glucoside (113).
8-Hydroxylation of quercetin, as in gossypetin-7-O-glucoside (128),
produces a much more marked effect than 6-hydroxylation. In compari-
son with quercetin-7-O-glucoside (113), spectrum 128 displays a
bathochromic shift in band II with a major increase in the intensity of
band IIa as seen with 6-hydroxylation (spectrum 127). 8-Hydroxylation
also causes an 11nm bathochromic shift of band I together with a major
intensification of a band at 340nm which is not seen in the quercetin
equivalent. When gossypetin is glycosylated at the 8-hydroxyl (e.g. in the
8-O-glucoside-3-O-sophoroside, 129), the spectrum reverts to that of a
quercetin-3-O-glycoside type, almost as if the influence of the 8-hydroxyl
had been largely negated by 8-glycosylation.
4.4. The myricetin (3,5,7,3’,4’,5’) oxygenation pattern
A comparison of the spectra of quercetin (108) and myricetin (132)
reveals that the extra oxygenation at C-5’ in the latter has little effect on
Maria da Graça Campos & Kenneth R. Markham
30
the spectrum apart from perhaps a slight enhancement of the band IIa
shoulder. This is true also for the equivalent glycosidic forms (cf. myricetin-
3-O-galactoside, 133, and 3-O-rhamnoside, 134, with the quercetin equiva-
lents, 109 and 112).
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TABLE I
Reference compounds grouped according to general compound type
(e.g. aromatic acids, dihydroflavonoids, flavones, and flavonols)
N.º 1. Aromatic acids RT max. nm
1 . benzoic acid 31.5 265sh-272-280sh
2 . salicylic acid 34.7 301
3 . p-hydroxybenzoic acid 18.1 255
4 . 2,4-dihydroxybenzoic acid 22.6 240sh-296sh-325
5 . 2,5-dihydroxybenzoic acid 18.6 235sh-325
6 . vanillic acid 21.9 258-290sh
7 . gallic acid 8.9 270
8 . syringic acid 24.2 274
9 . cinnamic acid 41 276
10 . o-coumaric acid 36 233sh-273-320sh
11 . m-coumaric acid 33 233sh-274-320sh
12 . p-coumaric acid 28.6 293sh-308
13 . caffeic acid 23.5 239sh-296sh-323
14 . ferulic acid 31.4 239sh-296sh-323
15 . isoferulic acid 32.9 239sh-296sh-323
16 . sinapic acid 32.2 325
17 . chlorogenic acid 22.8 245sh-296sh-323
18 . rosmarinic acid 35 250sh-290sh-320
N.º 2. Dihydroflavonoids RT max. nm
19 . naringenin 44.9 289-326sh
20 . eriodictyol 40.8 289-324sh
21 . eriodictyol-7-O-[rhamnosyl(1-2)glucoside] 32.5 289-334sh
22 . fustin 29.8 278-311sh
23 . dihydroquercetin 32.8 288-334sh
N.º 3. Flavones RT max. nm
24 . 5-hydroxy-4’-methoxyflavone 59 253sh-324-366sh-
392sh
25 . chrysin 56.3 266-312sh
26 . baicalein 53 277-321
27 . 5,7,2’-trihydroxyflavone 48.4 242sh-263-286sh-
337
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N.º 3. Flavones (cont.) RT max. nm
28 . apigenin 45.1 266-290sh-337
29 . apigenin-7-O-[rhamnosyl(1-2)glucoside] 35.7 267-339
30 . apiin (apigenin-7-O-[apiosyl(1-2) glucoside]) 35.6 267-335
31 . apigenin-7-O-glucoside 35,8 267-336
32 . vitexin 32.6 266-290sh-336
33 . isovitexin 39.1 274-329
34 . 2’’-O-glucosylvitexin 31.7 268-294sh-336
35 . saponarin 26.1 268-336
36 . genkwanin (7-O-methylapigenin) 57.1 267-290sh-331
37 . acacetin-7-O-[rhamnosyl(1-2)glucoside] 41.4 267-332
38 . 8-hydroxyapigenin-8-O-glucuronide 39.5 238sh- 270-295sh-
330
39 . 8-hydroxyapigenin-7-O-allosyl(1-2) glucoside 35.2 274-303-326
40 . scutellarein-6,4’-dimethylether 58 274-332
41 . 5,7,2’,5’-tetrahydroxyflavone 40.2 256sh-263-286sh-
308-359
42 . luteolin 41.6 253-267sh-291sh-
350
43 . luteolin-7-O-glucoside 33.6 254-267sh-348
44 . luteolin-3’-O-glucoside 36.5 240-268-288sh-342
45 . luteolin-5-O-glucoside 31.5 240sh-249-262sh-
288sh-302sh-343
46 . luteolin-7-O-rutinoside 32.7 254-267sh-348
47 . luteolin-7-O-[glucuronosyl(1-2)-glucuronide] 29.8 255-267sh-345
48 . luteolin-7,4’-di-O-glucuronide 30.7 247sh-267sh-335
49 . luteolin-7,3’-di-O-glucuronide 33.1 240-268-340
50 luteolin-3’,4’-di-O-glucuronide 34,5 271-291sh-323
51 . luteolin-7,3’,4’-tri-O-glucuronide 28 272-293sh-321
52 . orientin 27.1 254-268sh-290sh-
350






55 . chrysoeriol 46.7 241sh-252-269-
290sh-348
56 . chrysoeriol-5-O-glucoside 35 238sh-248sh-
262sh-343
57 . chrysoeriol-7-O-glucuro-glucuronide 26.8 225-242sh-267-333
58 . chrysoeriol-6,8-di-C-glucoside 28.7 253sh-267-344
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N.º 3. Flavones (cont.) RT max. nm
59 . diosmetin 7-O-[rhamnosyl(1-6)glucoside] 36.3 251-266sh-346
60 . 5,7-dihydroxy-2’,5’-dimethoxyflavone 58.4 256-sh-265-310sh-
355






63 . 6-hydroxyluteolin-7-O-[xylosyl(1-2)glucoside] 38.7 232sh-245sh-
253sh-282-345
64 . 6-hydroxyluteolin-7-O-[xylosyl(1-2) xyloside] 34.9 232sh-253sh-282-
344
65 8-hydroxyluteolin-7-O-glucoside 29,6 255sh-277-298sh-
340
66 8-hydroxyluteolin-8-O-glucoside 35,1 255sh-270-292sh-
352
67 . tricetin 38 247sh-266-296sh-
350
68 . tricetin-7-O-glucoside 30,7 247sh-266-350
69 . tricin 46.1 245-266-296sh-354
70 . tricin-5-O-glucoside 35 245-266-296sh-351
71 . tricin-7-O-[rhamnosyl(1-2)glucuronide] 36.2 248-267-296sh-351
72 . tricetin-3’,4’,5’-trimethylether 54.7 237sh-269-331
73 . scaposin 48.3 280-331
74 . 7-hydroxy-5,8,3’,4’-tetramethoxyflavone 42.6 249-270-340
N.º 4. Flavonols RT max. nm
75 . 2'-hydroxyflavonol 48.8 240-292sh-330
76 . galangin 57.8 237sh-263-288sh-
310-358
77 . 3',4'-dihydroxyflavonol 43.7 230sh-248-312sh-
327sh-360
78 . 3',4'-dimethoxyflavonol 57.2 230sh-248-312sh-
327sh-360
79 . 7,4'-di-O- 32.8 254-266sh-346
80 . 7,8,4'-trihydroxyflavonol 36.5 237sh-263-315-359
81 . 7,8,4'-trimethoxyflavonol 58 250sh-258-308sh-
330
82 . fisetin 37.2 253-305-320sh-354
83 . kaempferol 46.6 248sh-266-295sh-
318sh-366
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N.º 4. Flavonols (cont.) RT max. nm
84 . kaempferol-3-O-glucoside 35.6 265-290sh-320sh-
346
85 . kaempferol-3-O-rhamnoside 38.5 262-292sh-315sh-
342
86 . kaempferol-7-O-glucoside 35.8 248sh-265-322sh-
362
87 . kaempferol-3-O-[glucosyl(1-2)glucoside] 32.1 242sh-265-292sh-
322sh-346
88 . kaempferol-3-O-[rhamnosyl(1-2)glucoside] 33.2 265-290sh-320sh-
350
89 . kaempferol-3-O-[rhamnosyl(1-6)glucoside] 35.1 265-290sh-320sh-
348
90 . kaempferol-3,7-O-diglucoside 27.4 242sh-265-322sh-
345




























99 . datiscetin 45.7 255-308sh-346
100 . datiscetin-3-O-[rhamnosyl(1-6)glucoside] 33.9 258-304sh-332sh
101 . herbacetin-8-O-glucoside 38.5 250sh-269-326sh-
371
102 . herbacetin-3-O-glucosyl-8-O-glucuronide 29.8 269-295sh-326sh-
352sh













108 . quercetin 41.9 255-295sh-372
109 . quercetin-3-O-galactoside 33.5 255-266sh-294sh-
355
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N.º 4. Flavonols (cont.) RT max. nm
110 . quercetin-3-O-glucoside 33.8 255-266sh-294sh-
355
111 . quercetin-3-O-arabinoside 34.9 255-266sh-294sh-
354
112 . quercetin-3-O-rhamnoside 35.7 254-263sh-294sh-
348
113 . quercetin-7-O-glucoside 32.6 254-269sh-370
114 . quercetin-3-O-[glucosyl(1-2)glucoside] 30.6 255-266sh-294sh-
355
115 . quercetin-3-O-[rhamnosyl(1-6) galactoside] 32.7 255-266sh-294sh-
355
116 . quercetin-3-O-[rhamnosyl(1-6)glucoside] 33.1 255-264sh-294sh-
355
117 . 3-O-methylquercetin 43.4 255-263sh-297sh-
357
118 . isorhamnetin 47.3 255-266sh-306sh-
326sh-372
119 . isorhamnetin-3-O-galactoside 36 253-266sh-294sh-
352
120 . isorhamnetin-3-O-glucoside 36.3 255-266sh-294sh-
355
121 . isorhamnetin-3-O-[rhamnosyl(1-6) glucoside] 35.5 255-266sh-294sh-
355
122 . tamarixetin-7-O-rutinoside 35.9 253-269sh-369
123 . 5-O-methylisorhamnetin-3-O-glucoside 33.8 249-263sh-298sh-
344
124 . penta-O-methylquercetin 55.5 248-262sh-318sh-
346
125 . morin 39.5 252-262sh-290sh-
318sh-352
126 . patuletin-7-O-glucoside 33.5 256-272sh-372
127 . quercetagenin-7-O-glucoside 30.7 236sh-259-274sh-
358





130 . robinetin (5-deoxymyricetin) 33,7 246-316-358
131 . 3-O-methyl-7,8,3',4'-tetrahydroxyflavonol 33.2 255-265sh-310sh-
345
132 . myricetin 37.2 252-263sh-298sh-
371
133 . myricetin-3-O-galactoside 30.8 250-261sh-300sh-
354
134 myricetin-3-O-rhamnoside 32.8 250sh-261-300sh-
349
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TABLE II
Reference compounds listed in order of retention times (RT)
RT N.º Compound max. nm
8,9 7 . gallic acid 270
18,1 3 . p-hydroxybenzoic acid 255
18,6 5 . 2,5-dihydroxybenzoic acid 235sh-325
21,9 6 . vanillic acid 258-290sh
22,6 4 . 2,4-dihydroxybenzoic acid 240sh-296sh-325
22,8 17 . chlorogenic acid 245sh-296sh-323
23,5 13 . caffeic acid 239sh-296sh-323
23,7 92 . kaempferol-7-O-glucoside-3-O-
[glucosyl(1-2)glucoside]
242sh-263-315sh-344
24,2 8 . syringic acid 274
24,6 129 . gossypetin-8-O-glucoside-3-O-
[glucosyl (1-2)glucoside]
259sh-268-356
26,1 35 . saponarin 268-336




26,8 57 . chrysoeriol-7-O-glucuro-
glucuronide
225-242sh-267-333
27,0 53 . isoorientin 254sh-268-290sh-350
27,1 52 . orientin 254-268sh-290sh-350
27,4 90 . kaempferol-3,7-O-diglucoside 242sh-265-322sh-345
28 51 . luteolin-7,3’,4’-tri-O-glucuronide 272-293sh-321
28,6 12 . p-coumaric acid 293sh-308
28,7 58 . chrysoeriol-6,8-di-C-glucoside 253sh-267-344







29,7 62 . 6-hydroxyluteolin-7-O-
[glucosyl(1-2) glucoside]
232sh-253sh-281-344
29,8 22 . fustin 278-311sh
29,8 47 . luteolin-7-O-[glucuronosyl(1-2)-
glucuronide]
255-267sh-345
29,8 102 . herbacetin-3-O-glucosyl-8-O-
glucuronide
269-295sh-326sh-352sh
30,1 94 . kaempferol-3-O-[6-
acetylglucoside]-7-O-glucoside
242sh-265-315sh-346
30,6 114 . quercetin-3-O-[glucosyl(1-
2)glucoside]
255-266sh-294sh-355
30,7 68 . tricetin-7-O-glucoside 247sh-266-350
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RT N.º Compound max. nm
30,7 127 . quercetagenin-7-O-glucoside 236sh-259-274sh-358
30.7 48 . luteolin-7,4’-di-O-glucuronide 247sh-267sh-335
30,8 133 . myricetin-3-O-galactoside 250-261sh-300sh-354
30,9 106 . 7-O-methylherbacetin-3-O-
[glucosyl(1-2) glucoside]
278-307-330-370sh
31,4 14 . ferulic acid 239sh-296sh-323
31,4 104 . 8-O-methylherbacetin-3-O-
[glucosyl(1-2)glucoside]
274-300sh-324-355sh
31,5 1 . benzoic acid 265sh-272-280sh
31,5 45 . luteolin-5-O-glucoside 240sh-249-262sh-288sh-
302sh-343
31,7 34 . 2’’-O-glucosylvitexin 268-294sh-336




31,8 128 . gossypetin-7-O-glucoside 259-269sh-300sh-340sh-
381
32 93 . kaempferol-3-O-glucoside-7-O-
rhamnoside
242sh-265-315sh-344
32 98 . 7-O-methylkaempferol-3-O-
[rhamnosyl(1-2)glucoside]
242sh-263-315sh-344




32,2 16 . sinapic acid 325
32,5 21 . eriodictyol-7-O-[rhamnosyl(1-
2)glucoside]
289-334sh
32,6 32 . vitexin 266-290sh-336
32,6 113 . quercetin-7-O-glucoside 254-269sh-370
32,7 46 . luteolin-7-O-rutinoside 254-267sh-348
32,7 115 . quercetin-3-O-[rhamnosyl(1-6)
galactoside]
255-266sh-294sh-355
32,8 23 . dihydroquercetin 288-334sh
32,8 79 . 7,4'-di-O- 254-266sh-346
32,8 134 myricetin-3-O-rhamnoside 250sh-261-300sh-349
32,9 15 . isoferulic acid 239sh-296sh-323
33 11 . m-coumaric acid 233sh -274-320sh
33,1 49 . luteolin-7,3’-di-O-glucuronide 240-268-340
33,1 116 . quercetin-3-O-[rhamnosyl(1-
6)glucoside]
255-264sh-294sh-355
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33,2 88 . kaempferol-3-O-[rhamnosyl(1-
2)glucoside]
265-290sh-320sh-350
33,2 131 . 3-O-methyl-7,8,3',4'-
tetrahydroxyflavonol
255-265sh-310sh-345
33,5 109 . quercetin-3-O-galactoside 255-266sh-294sh-355
33,5 126 . patuletin-7-O-glucoside 256-272sh-372
33,6 43 . luteolin-7-O-glucoside 254-267sh-348
33,7 130 . robinetin (5-deoxymyricetin) 246-316-358
33,8 110 . quercetin-3-O-glucoside 255-266sh-294sh-355
33,8 123 . 5-O-methylisorhamnetin-3-O-
glucoside
249-263sh-298sh-344
33,9 100 . datiscetin-3-O-[rhamnosyl(1-
6)glucoside]
258-304sh-332sh




34,5 50 luteolin-3’,4’-di-O-glucuronide 271- 291sh-323
34,7 2 . salicylic acid 301
34,9 64 . 6-hydroxyluteolin-7-O-
[xylosyl(1-2) xyloside]
232sh-253sh-282-344
34,9 111 . quercetin-3-O-arabinoside 255-266sh-294sh-354
35 18 . rosmarinic acid 250sh-290sh-320
35 56 . chrysoeriol-5-O-glucoside 238sh-248sh-262sh-343




35,1 89 . kaempferol-3-O-[rhamnosyl(1-
6)glucoside]
265-290sh-320sh-348
35,2 39 . 8-hydroxyapigenin-7-O-
allosyl(1-2) glucoside
274-303-326
35,5 121 . isorhamnetin-3-O-
[rhamnosyl(1-6) glucoside]
255-266sh-294sh-355
35,6 30 . apiin (apigenin-7-O-[apiosyl(1-
2) glucoside])
267-335
35,6 84 . kaempferol-3-O-glucoside 265-290sh-320sh-346
35,7 29 . apigenin-7-O-[rhamnosyl(1-
2)glucoside]
267-339
35,7 61 . 6-hydroxyluteolin 251sh-278-310sh-344
35,7 112 . quercetin-3-O-rhamnoside 254-263sh-294sh-348
35,8 31 . apigenin-7-O-glucoside 267-336
RT N.º Compound max. nm
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RT N.º Compound max. nm
35,8 86 . kaempferol-7-O-glucoside 248sh-265-322sh-362
35,9 122 . tamarixetin-7-O-rutinoside 253-269sh-369
36 10 . o-coumaric acid 233sh-273-320sh
36 119 . isorhamnetin-3-O-galactoside 253-266sh-294sh-352
36,2 71 . tricin-7-O-[rhamnosyl
(1-2)glucuronide]
248-267-296sh-351
36,3 59 . diosmetin 7-O-[rhamnosyl
(1-6)glucoside]
251-266sh-346
36,3 120 . isorhamnetin-3-O-glucoside 255-266sh-294sh-355
36,5 44 . luteolin-3’-O-glucoside 240-268-288sh-342
36,5 80 . 7,8,4'-trihydroxyflavonol 237sh-263-315-359
37,2 82 . fisetin 253-305-320sh-354
37,2 132 . myricetin 252-263sh-298sh-371
38 67 . tricetin 247sh-266-296sh-350
38,5 101 . herbacetin-8-O-glucoside 250sh-269-326sh-371
38,5 85 . kaempferol-3-O-rhamnoside 262-292sh-315sh-342




39,1 33 . isovitexin 274-329
39,5 38 . 8-hydroxyapigenin-8-O-
glucuronide
238sh-270-295sh-330
39,5 125 . morin 252-262sh-290sh-318sh-
352
40,2 41 . 5,7,2’,5’-tetrahydroxyflavone 256sh-263-286sh-308-359
40,8 20 . eriodictyol 289-324sh
41 9 . cinnamic acid 276
41,4 37 . acacetin-7-O-[rhamnosyl(1-
2)glucoside]
267-332
41,6 42 . luteolin 253-267sh-291sh-350
41,9 108 . quercetin 255-295sh-372
42,6 74 . 7-hydroxy-5,8,3’,4’-
tetramethoxyflavone
249-270-340
43 107 . 7,8-di-O-methylherbacetin-3-O-
[2-ferulylglucoside]
279-310sh-329
43,4 117 . 3-O-methylquercetin 255-263sh-297sh-357
43,7 77 . 3',4'-dihydroxyflavonol 230sh-248-312sh-327sh-
360
44,9 19 . naringenin 289-326sh
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RT N.º Compound max. nm
45,1 28 . apigenin 266-290sh-337
45,6 105 . 7-O-methylherbacetin 276-307sh-329-387
45,7 99 . datiscetin 255-308sh-346
46,1 69 . tricin 245-266-296sh –354
46,3 103 . 8-O-methylherbacetin 250sh-272-325sh-375
46,6 83 . kaempferol 248sh-266-295sh-318sh-
366
46,7 55 . chrysoeriol 241sh-252-269-290sh-348
47,3 118 . isorhamnetin 255-266sh-306sh-326sh-
372
48,3 73 . scaposin 280-331
48,4 27 . 5,7,2’-trihydroxyflavone 242sh-263-286sh-337
48,8 75 . 2'-hydroxyflavonol 240-292sh-330
53 26 . baicalein 277-321
54,7 72 . tricetin-3’,4’,5’-trimethylether 237sh-269-331
55,5 124 . penta-O-methylquercetin 248-262sh-318sh-346
56,3 25 . chrysin 266-312sh
57,1 36 . genkwanin(7-O-
methylapigenin)
267-290sh-331
57,2 78 . 3',4'-dimethoxyflavonol 230sh-248-312sh-327sh-
360
57,8 76 . galangin 237sh-263-288sh-310-358
58 40 . scutellarein-6,4’-dimethylether 274-332
58 81 . 7,8,4'-trimethoxyflavonol 250sh-258-308sh-330
58,2 97 . kaempferol-4'-O-methylether 248sh-265-295sh-318sh-
362
58,4 60 . 5,7-dihydroxy-2’,5’-
dimethoxyflavone
256-sh-265-310sh-355
59 24 . 5-hydroxy-4’-methoxyflavone 253sh-324-366sh-392sh
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UV-SPECTRA
(Página deixada propositadamente em branco)
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1. PHENOLIC ACIDS
1 – benzoic  acid
(RT= 31.5; λ
max.
= 265sh, 272, 280sh nm)





240.00 260.00 280.00 300.00 320.00 340.00 360.00 380.00 400.00
CO2H
HO
240.00 260.00 280.00 300.00 320.00 340.00 360.00 380.00
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4 – 2,4-dihydroxybenzoic acid
(RT= 22.6; λ
max.
= 240sh, 296sh, 325 nm)
CO2H
OH




240.00 260.00 280.00 300.00 320.00 340.00 360.00 380.00
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5 – 2,5-dihydroxybenzoic acid
(RT=18.6; λ
max.
= 235sh, 325 nm)
6 – vanillic acid
(RT= 21.9; λ
max.
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7 – gallic acid







240.00 260.00 280.00 300.00 320.00 340.00 360.00 380.00
Structure information from HPLC  and on-line measured absorption spectra
51




10 – o-coumaric acid
(RT= 36; λ
max 
= 233sh, 273, 320sh nm)
CO2H
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12 – p-coumaric acid
(RT= 28.6; λ
max.
= 293sh, 308 nm)
11 – m-coumaric acid
(RT= 33;  λ
max  
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13 – caffeic acid
(RT= 23.5; λ
max.
= 239sh, 296sh, 323 nm)
14 – ferulic acid
(RT= 31.4; λ
max.
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15 – isoferulic acid
(RT= 32.9;  λ
max. 
= 239sh, 296sh, 323 nm)
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17 – chlorogenic acid
(RT= 22.8; λ
max.
= 245sh, 296sh, 323 nm)
18 – rosmarinic acid
(RT= 35;  λ
max.
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(RT = 59; λ
max.
= 253sh, 324, 366sh, 392sh nm)
25 –  chrysin
(RT = 56.3; λ
max. 
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26 – baicalein
(RT = 53;  λ
max. 
= 277, 321 nm)
27 – 5,7,2'-trihydroxyflavone
(RT =  48.4 ; λ
max. 
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28 – apigenin
(RT = 45.1;  λ
max.
= 266, 290sh, 337 nm)
29 – apigenin-7-O-[rhamnosyl(1-2)glucoside]
(RT = 35.7;  λ
max. 
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30 – apigenin-7-O-[apiosyl(1-2)glucoside]
(RT = 35.6;  λ
max.
= 267, 335 nm)
31 – apigenin-7-O-glucoside
(RT = 35.8;  λ
max.
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32 – vitexin
(RT = 32.6;  λ
max. 
= 266, 290sh, 336 nm)
33 – isovitexin
(RT = 39.1; λ
max. 
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34 – 2'’-O-glucosylvitexin
(RT = 31.7;  λ
max. 
= 268, 294sh, 336 nm)
35 – saponarin
(RT = 26.1;  λ
max. 
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36 – genkwanin
(RT = 57.1; λ
max.
= 267, 290sh, 331 nm)
37 – acacetin-7-O-[rhamnosyl(1-2)glucoside]
(RT = 41.4;  λ
max. 
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38 – 8-hydroxy-apigenin-8-O-glucuronide
(RT = 39.5; λ
max. 
= 238sh, 270, 295sh, 330 nm)
39 – 8-hydroxy-apigenin-7-O-[allosyl(1-2)glucoside]
(RT = 35.2; λ
max. 
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40 – scutellarein-6,4'-dimethylether
(RT = 58 ;  λ
max. 
= 274, 332 nm)
41 – 5,7,2',5'-tetrahydroxyflavone
(RT =  40.2; λ
max.
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42 – luteolin
(RT = 41.6; λ
max. 
= 253, 267sh, 291sh, 350 nm)
43 – luteolin-7-O-glucoside
(RT = 33.6; λ
max. 
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44 – luteolin-3'-O-glucoside
(RT = 36.5; λ
max. 
= 240, 268, 288sh, 342 nm)
45 – luteolin-5-O-glucoside
(RT = 31.5; λ
max. 
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46 – luteolin-7-O-rutinoside
(RT = 32.7; λ
max. 
= 254, 267sh, 348 nm)
47 – luteolin-7-O-[glucuronosyl(1-2)glucuronide]
(RT = 29.8; λ
max. 
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48 – luteolin-7,4'-di-O-glucuronide
(RT = 30.7; λ
max. 
= 247sh, 267, 335 nm)
49 – luteolin-7,3'-di-O-glucuronide
(RT = 33.1; λ
max. 
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50 – luteolin-3’,4’-di-O-glucuronide
(RT = 34.5; λ
max. 
= 271, 291sh, 323 nm)
51 – luteolin-7,3',4'-tri-O-glucuronide
( RT = 28; λ
max. 
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52 – orientin
(RT = 27.1; λ
max. 
= 254, 268sh, 290sh, 350 nm )
53 – isoorientin
(RT = 27.0; λ
max. 
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54 – neocarlinoside
(RT = 28.9; λ
max. 
= 256sh, 271, 294sh, 350 nm)
55 – chrysoeriol
(RT = 46.7; λ
max. 
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56 – chrysoeriol-5-O-glucoside
     (RT =  35; λ
max. 
= 238sh, 248sh, 262sh, 343 nm)
57 – chrysoeriol-7-O-glucuro-glucuronide
     (RT = 26.8; λ
max. 
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58 – chrysoeriol-6,8-di-C-glucoside
     (RT = 28.7; λ
max. 
= 253sh, 267, 344 nm)
59 – diosmetin-7-O-[rhamnosyl(1-6)glucoside]
     (RT = 36.3; λ
max. 
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60 – 5,7-dihydroxy-2',5'-dimethoxyflavone
      (RT = 58.4; λ
max. 
= 256sh, 265, 310sh, 355 nm)
61 – 6-hydroxyluteolin
     (RT = 35.7; λ
max. 
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62 – 6-hydroxyluteolin-7-O-[glucosyl(1-2)glucoside]
    (RT = 29.7; λ
max. 
= 232sh, 253sh, 281, 344 nm)
63 – 6-hydroxyluteolin-7-O-[xylosyl(1-2)glucoside]
     (RT = 38.7; λ
max. 
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64 – 6-hydroxyluteolin-7-O-[xylosyl(1-2)xyloside]
     (RT = 34.9; λ
max. 
= 232sh, 253sh, 282, 344 nm)
65 – 8-hydroxyluteolin-7-O-glucoside
     (RT = 29.6; λ
max. 
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66 – 8-hydroxy-luteolin-8-O-glucoside
     (RT = 35.1; λ
max. 
= 255sh, 270, 292sh, 352 nm)
67 – tricetin
(RT = 38.0; λ
max. 
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68 – tricetin-7-O-glucoside
     (RT = 30.7; λ
max. 
= 247sh, 266, 350 nm)
69 – tricin
(RT = 46.1; λ
max. 
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70 – tricin-5-O-glucoside
     (RT = 35; λmax. = 245, 266, 296sh, 351 nm)
71 – tricin-7-O-[rhamnosyl(1-2)glucuronide]
     (RT = 36.2; λ
max. 


















240.00 260.00 280.00 300.00 320.00 340.00 360.00 380.00
Structure information from HPLC  and on-line measured absorption spectra
83
72 – tricetin-3',4',5'-trimethylether
     (RT = 54.7; λ
max. 
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73 – scaposin
(RT = 48.3; λ
max. 
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74 – 7-hydroxy-5,8,3',4'-tetramethoxyflavone
     (RT = 42.6; λ
max. 
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(RT = 48.8; λ
max. 
= 240, 292sh, 330 nm)
76 – galangin
(RT = 57.8; λ
max. 
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77 – 3',4'-dihydroxyflavonol
     (RT = 43.7; λ
max. 
= 230sh, 248, 312sh, 327sh, 360 nm)
78 – 3',4'-dimethoxyflavonol
     (RT = 57.2; λ
max. 
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79 – 7,4'-di-O-dimethylflavonol
     (RT = 32.8; λ
max. 
= 254, 266sh, 346 nm)
80 – 7,8,4'-trihydroxyflavonol
     (RT = 36.5; λ
max.
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81 – 7,8,4’-trimethoxyflavonol
     (RT = 58; λ
max. 
= 250sh, 258, 308sh, 330 nm)
82 – fisetin
(RT = 37.2; λ
max. 
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83 – kaempferol
     (RT = 46.6; λ
max. 
= 248sh, 266, 295sh, 318sh, 366 nm)
84 – kaempferol-3-O-glucoside
     (RT = 35.6; λ
max. 
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85 – kaempferol-3-O-rhamnoside
     (RT=38.5; λ
max.
= 262, 292sh, 315sh, 342 nm)
86 – kaempferol-7-O-glucoside
     (RT = 35.8 ; λ
max. 
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87 – kaempferol-3-O-[glucosyl(1-2)glucoside]
     (RT= 32.1; λ
max.
= 242sh,  265, 292sh, 322sh, 346 nm)
88 – kaempferol-3-O-[rhamnosyl(1-2)glucoside]
     (RT=33.2; λ
max.
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89 – kaempferol-3-O-[rhamnosyl(1-6)glucoside]
     (RT = 35.1; λ
max. 
= 265, 290sh, 320sh, 348 nm)
90 – kaempferol-3,7-O-diglucoside
     (RT = 27.4; λ
max. 
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91 – kaempferol-3-O-[rhamnosyl(1-6)glucoside]-7-O-rhamnoside
(RT = 31.8; λ
max  
= 245sh, 266, 292sh, 316sh, 345 nm)
92 – kaempferol-3-O-[glucosyl(1-2)glucoside]-7-O-glucoside
    (RT = 23.7; λ
max. 
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93 – kaempferol-3-O-glucoside-7-O-rhamnoside
     (RT = 32; λ
max. 
= 242sh, 265, 315sh, 344 nm)
94 – kaempferol-3-O-[6-acetylglucoside]-7-O-glucoside
     (RT = 30.1; λ
max. 
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95 – kaempferol-3-O-[6-acetylglucoside]-7-O-rhamnoside
    (RT = 34.3;  λ
max.
=   242sh, 266, 315sh, 346 nm)
96 – kaempferol-3-O-[2-sinapoylglucosyl(1-2)glucoside]-7-O-glucoside
(RT = 26.8; λ
max. 
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97 – kaempferol-4'-O-methylether
    (RT = 58.2; λ
max. 
= 248sh, 265, 295sh, 318sh, 362 nm)
98  – 7-O-methylkaempferol-3-O-[rhamnosyl(1-2)glucoside]
    (RT = 32; λ
max. 
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=  255, 308sh, 346 nm)
100 – datiscetin-3-O-[rhamnosyl(1-6)glucoside]
      (RT=33.9; λ
max 
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101 – herbacetin-8-O-glucoside
     (RT = 38.5; λ
max. 
= 250sh, 269, 326sh, 371 nm)
102 – herbacetin-3-O-glucosyl-8-O-glucuronide
    (RT = 29.8; λ
max. 
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103 – 8-O-methylherbacetin
     (RT = 46.3; λ
max. 
= 250sh, 272, 325sh, 375 nm)
104 – 8-O-methylherbacetin-3-O-[glucosyl(1-2)glucoside]
     (RT = 31.4; λ
max. 
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105 – 7-O-methylherbacetin
     (RT = 45.6; λ
max. 
= 276, 307sh, 329, 387 nm)
106 – 7-O-methylherbacetin-3-O-[glucosyl(1-2)glucoside]
      (RT = 30.9; λ
max. 
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107 – 7,8-di-O-methylherbacetin-3-O-[2-ferulylglucoside]
      (RT = 43; λ
max. 
= 279, 310sh, 329 nm)
108 – quercetin
(RT = 41.9; λ
max.
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109 – quercetin-3-O-galactoside
     (RT = 33.5; λ
max. 
= 255, 266sh, 294sh, 355 nm)
110 – quercetin-3-O-glucoside
     (RT = 33.8; λ
max. 
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111 – quercetin-3-O-arabinoside
     (RT= 34.9; λ
max. 
= 255, 266sh, 294sh, 354 nm)
112 – quercetin-3-O-rhamnoside
     (RT = 35.7; λ
max. 
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113  – quercetin-7-O-glucoside
     (RT = 32.6; λ
max.
= 254, 269sh, 370 nm)
114  – quercetin-3-O-[glucosyl(1-2)glucoside]
     (RT = 30.6; λ
max. 


















240.00 260.00 280.00 300.00 320.00 340.00 360.00 380.00
Structure information from HPLC  and on-line measured absorption spectra
105
115 – quercetin-3-O-[rhamnosyl(1-6)galactoside]
     (RT = 32.7; λ
max. 
= 255, 266sh, 294sh, 355 nm)
116 – quercetin-3-O-[rhamnosyl(1-6)glucoside]
     (RT = 33.1; λ
max. 
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117 – 3-O-methylquercetin
     (RT = 43.4 ; λ
max. 
= 255, 263sh, 297sh, 357 nm)
118 – isorhamnetin
     (RT = 47.3; λ
max.  
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119 – isorhamnetin-3-O-galactoside
     (RT = 36; λ
max. 
= 253, 266sh, 294sh, 352 nm)
120 – isorhamnetin-3-O-glucoside
     (RT = 36.3; λ
max. 
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121 – isorhamnetin-3-O-[rhamno(1-6)glucoside]
     (RT = 35.5; λ
max. 
= 255, 266sh, 294sh, 355 nm)
122 – tamarixetin-7-O-rutinoside
      (RT = 35.9; λ
max. 
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123 – 5-O-methylisorhamnetin-3-O-glucoside
     (RT = 33.8; λ
max. 
= 249, 263sh, 298sh, 344 nm)
124 – penta-O-methylquercetin
     (RT = 55.5; λ
max. 
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125 – morin
(RT = 39.5; λ
max. 
= 252, 262sh, 290sh, 318sh, 352 nm)
126 – patuletin-7-O-glucoside
     (RT = 33.5; λ
max. 
= 256, 272sh, 372 nm)
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127 – quercetagenin-7-O-glucoside
     (RT = 30.7; λ
max. 
= 236sh, 259, 274sh, 358 nm)
128 – gossypetin-7-O-glucoside
     (RT = 31.8; λ
max. 
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129 – gossypetin-8-O-glucoside-3-O-[glucosyl(1-2)glucoside]
(RT = 24.6; λ
max. 
= 259sh, 268, 356 nm)
130 – robinetin
(RT = 33.7; λ
max. 
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131 – 3-O-methyl-7,8,3',4'-tetrahydroxyflavonol
     (RT = 33.2; λ
max. 
= 255, 265sh, 310sh, 345 nm)
132 – myricetin
(RT = 37.2; λ
max. 
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133 – myricetin-3-O-galactoside
     (RT = 30.8; λ
max. 
= 250, 261sh, 300sh, 354 nm)
134 – myricetin-3-O-rhamnoside
     (RT = 32.8; λ
max. 
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COMPOUND INDEX
acacetin-7-O-[rhamnosyl(1-2)glucoside]  36, 43
apigenin  20, 21, 22, 23, 24, 27, 36, 42, 43, 44, 61, 62, 66
apigenin-7-O-[rhamnosyl(1-2)glucoside]  36, 42
apigenin-7-O-glucoside  20, 36, 42
apiin  (apigenin-7-O-[apiosyl(1-2) glucoside])  36, 42
baicalein  19, 20, 35, 44
benzoic acid  11, 17, 18, 35, 40, 41, 48, 49
caffeic acid  18, 35, 40, 53
chlorogenic acid  35, 40, 55
chrysin  19, 20, 22, 35, 44
chrysoeriol  22, 23, 36, 40, 42, 44, 74, 75, 76
chrysoeriol-5-O-glucoside  22, 36, 42
chrysoeriol-6,8-di-C-glucoside  36, 40, 76
chrysoeriol-7-O-glucuro-glucuronide  36, 40, 75
cinnamic acid  11, 17, 18, 35, 43
m-coumaric acid  35, 41, 52
o-coumaric acid  18, 35, 43, 51
p-coumaric acid  35, 40, 52
datiscetin  38, 42, 44
datiscetin-3-O-[rhamnosyl(1-6)glucoside]  38, 42
dihydroquercetin  19, 35, 41, 58
2,4-dihydroxybenzoic acid  17, 35, 40, 48
2,5-dihydroxybenzoic acid  35, 40, 49
5,7-dihydroxy-2',5'-dimethoxyflavone  77
3',4'-dihydroxyflavonol  25, 37, 43
3',4'-dimethoxyflavonol  25, 37, 44, 86
7,4'-di-O-methylflavonol  37, 41
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7,8-di-O-methylherbacetin-3-O-[2-ferulylglucoside]  38, 43
diosmetin 7-O-[rhamnosyl(1-6)glucoside]  37, 43
eriodictyol  19, 35, 41, 43, 57
eriodictyol-7-O-[rhamnosyl(1-2)glucoside]  35, 41, 57
ferulic acid  18, 27, 35, 41, 53, 54
fisetin  25, 37, 43
fustin  18, 35, 40, 57
galangin  25, 26, 37, 44, 85
gallic acid  35, 40, 50
genkwanin(7-O-methylapigenin)  44
2’’-O-glucosylvitexin  21, 36, 41
gossypetin-7-O-glucoside  29, 39, 41
gossypetin-8-O-glucoside-3-O-[glucosyl (1-2)glucoside  40
herbacetin-3-O-glucosyl-8-O-glucuronide  38, 40, 98
herbacetin-8-O-glucoside  38, 43
8-hydroxyapigenin-7-O-allosyl(1-2) glucoside  36, 42
8-hydroxyapigenin-8-O-glucuronide  21, 36, 43
p-hydroxybenzoic acid  35, 40, 48
2'-hydroxyflavonol  37, 44
6-hydroxyluteolin  23, 37, 40, 42, 43, 77, 78
6-hydroxyluteolin-7-O-[glucosyl(1-2) glucoside]  37, 40, 78
8-hydroxyluteolin-7-O-glucoside  37, 40, 79
8-hydroxyluteolin-8-O-glucoside  37, 42
6-hydroxyluteolin-7-O-[xylosyl(1-2)glucoside]  37, 43
6-hydroxyluteolin-7-O-[xylosyl(1-2) xyloside]  37, 42
5-hydroxy-4'-methoxyflavone  19, 59
isoferulic acid  18, 35, 41, 54
isoorientin  36, 40, 73
isorhamnetin  28, 29, 39, 42, 43, 44, 106
isorhamnetin-3-O-[rhamnosyl(1-6) glucoside]  39, 42
isorhamnetin-3-O-galactoside  39, 43
isorhamnetin-3-O-glucoside  29, 39, 42, 43
isovitexin  20, 36, 43
kaempferol  25, 26, 27, 37, 38, 40, 41, 42, 43, 44, 89, 91, 92, 94, 95
kaempferol-3-O-[2-sinapoylglucosyl(1-2)glucoside]-7-O-glucoside  95
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kaempferol-3-O-[6-acetylglucoside]-7-O-glucoside  38, 40, 94
kaempferol-3-O-[6-acetylglucoside]-7-O-rhamnoside  38, 42
kaempferol-3-O-[glucosyl(1-2)glucoside]  38, 41, 91
kaempferol-3-O-[rhamnosyl(1-2)glucoside]  38, 41, 42
kaempferol-3-O-[rhamnosyl(1-6) glucoside]-7-O-rhamoside  38, 41
kaempferol-3-O-[rhamnosyl(1-6)glucoside]  38, 42, 92
kaempferol-3-O-glucoside  38, 41, 42
kaempferol-3-O-glucoside-7-O-rhamnoside  38, 41
kaempferol-3-O-rhamnoside  38, 43
kaempferol-3,7-O-diglucoside  38, 40, 92
kaempferol-4'-O-methylether  38, 44, 96
kaempferol-7-O-glucoside  26, 27, 38, 40, 43
kaempferol-7-O-glucoside-3-O-[glucosyl(1-2)glucoside  38, 40
luteolin  21, 22, 23, 24, 36, 37, 40, 41, 42, 43, 68, 70, 71, 72, 77, 78, 79
luteolin-3’,4’-di-O-glucuronide  22, 36, 42
luteolin-5-O-glucoside  22, 36, 41
luteolin-7-O-[glucuronosyl(1-2)-glucuronide]  36, 40
luteolin-7-O-glucoside  21, 36, 37, 40, 42, 68, 79
luteolin-7-O-rutinoside  21, 36, 41
luteolin-7,3',4'-tri-O-glucuronide  72
luteolin-7,4'-di-O-glucuronide  71
m-coumaric acid  35, 41, 52
3-O-methyl-7,8,3',4'-tetrahydroxyflavonol  39, 42
5-O-methylisorhamnetin-3-O-glucoside  29, 39, 42
7-O-methylherbacetin  27, 38, 41, 44, 100
8-O-methylherbacetin  27, 38, 41, 44
7-O-methylherbacetin-3-O-[glucosyl(1-2) glucoside]  38, 41
8-O-methylherbacetin-3-O-[glucosyl(1-2)glucoside]  38, 41
7-O-methylkaempferol-3-O-[rhamnosyl(1-2)glucoside]  38, 41
3-O-methylquercetin  28, 39, 43
morin  39, 43
myricetin  29, 30, 39, 41, 42, 43, 113, 114
myricetin-3-O-galactoside  30, 39, 41, 114
myricetin-3-O-rhamnoside  39, 41, 114
naringenin  19, 35, 43, 56
neocarlinoside(luteolin-6-C-glucoside-8-C-arabinoside  36, 40
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o-coumaric acid  18, 35, 43, 51
orientin  20, 21, 36, 40, 73
p-coumaric acid  35, 40, 52
p-hydroxybenzoic acid  35, 40, 48
patuletin-7-O-glucoside  29, 39, 42
penta-O-methylquercetin  39, 44
quercetagenin-7-O-glucoside  39, 41, 111
quercetin  14, 19, 25, 26, 27, 28, 29, 30, 35, 38, 39, 40, 41, 42, 43, 44, 58, 101,
104, 105
quercetin-3-O-[glucosyl(1-2)glucoside]  39, 40, 104
quercetin-3-O-[rhamnosyl(1-6) galactoside]  39, 41
quercetin-3-O-[rhamnosyl(1-6)glucoside]  39, 41
quercetin-3-O-arabinoside  39, 42
quercetin-3-O-galactoside  28, 38, 42
quercetin-3-O-glucoside  28, 39, 42
quercetin-3-O-rhamnoside  14, 39, 42
quercetin-7-O-glucoside  28, 29, 39, 41
robinetin (5-deoxymyricetin)  39, 42
rosmarinic acid  35, 42, 55
salicylic acid  35, 42, 47
saponarin  36, 40, 64
scaposin  24, 37, 44
scutellarein-6,4'-dimethylether  67
sinapic acid  35, 41, 54
syringic acid  35, 40, 50
tamarixetin-7-O-rutinoside  28, 39, 43
tricetin-7-O-glucoside  24, 37, 40, 81
tricin  22, 24, 37, 42, 43, 44
tricin-5-O-glucoside  24, 37, 42
tricin-7-O-[rhamnosyl(1-2)glucuronide]  37, 43
5,7,2'-trihydroxyflavone  60
7,8,4'-trihydroxyflavonol  37, 43
7,8,4'-trimethoxyflavonol  37, 44
vanillic acid  35, 40, 49
vitexin  20, 21, 36, 41, 43, 63
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